The earnings call reflects a mixed sentiment with notable achievements in the launch of Evolysse and international expansion, contrasted by significant challenges in the U.S. toxin market and a revised financial outlook due to economic headwinds.

Company Guidance -

Q3 2025

During the call, Evolus provided updated guidance for 2025, revising their revenue expectations to a range of $295 million to $305 million, representing an 11% to 15% growth over 2024. They adjusted their non-GAAP operating expense guidance to $208 million to $213 million, aiming for more than $25 million in cost savings primarily from reductions in general and administrative expenses. Evolus maintained a long-term revenue target of $700 million by 2028, with a goal to achieve a 20% non-GAAP operating income margin. Despite challenges in the U.S. aesthetic toxin market, the company reported maintaining a 14% market share in the first half of 2025, up from 13% in 2024. They also noted a record high of over 224,000 Evolus Rewards redemptions, with 65% from repeat patients, indicating strong consumer satisfaction. The recent launch of Evolysse contributed $9.7 million in revenue, and its full-year revenue contribution is now expected to be 10% to 12%. The company is also focusing on international expansion, with Evolus active in nine markets outside the U.S., targeting $100 million in international revenue by 2028.

Evolysse Launch Success

Evolysse exceeded expectations in its first quarter, generating $9.7 million in revenue and marking the strongest first-quarter filler launch in over a decade. Over 4,000 healthcare providers have been trained since its launch.

Market Share Growth

Jeuveau maintained a 14% market share in the U.S. toxin market despite a challenging environment, reflecting an increase from the full year 2024 share of 13%.

International Expansion

The company is active in 9 markets outside the U.S., covering over 70% of the international total addressable market, with a goal to achieve $100 million in international revenue by 2028.

Positive Consumer Feedback

Evolus Rewards redemptions hit a record high of over 224,000, with 65% from repeat patients, highlighting brand strength and consumer satisfaction.

Evolus (EOLS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

EOLS Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 11, 2025	2025 (Q3)	-0.15 / -	-0.162	―	―	―
Aug 05, 2025	2025 (Q2)	-0.10 / -0.25	-0.039	-533.33% (-0.21)
May 07, 2025	2025 (Q1)	-0.14 / -0.15	-0.083	-79.52% (-0.07)	―
Mar 04, 2025	2024 (Q4)	0.02 / 0.03	-0.124	126.61% (+0.16)
Nov 06, 2024	2024 (Q3)	-0.12 / -0.16	-0.165	1.82% (<+0.01)
Jul 31, 2024	2024 (Q2)	-0.05 / -0.04	-0.195	80.00% (+0.16)
May 07, 2024	2024 (Q1)	-0.15 / -0.08	-0.151	45.03% (+0.07)
Mar 07, 2024	2023 (Q4)	-0.07 / -0.12	-0.137	9.49% (+0.01)
Nov 07, 2023	2023 (Q3)	-0.22 / -0.17	-0.278	40.65% (+0.11)
Aug 02, 2023	2023 (Q2)	-0.25 / -0.20	-0.326	40.18% (+0.13)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

EOLS Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$8.91	$6.37	-28.51%
May 07, 2025	$11.76	$10.09	-14.20%
Mar 04, 2025	$14.35	$14.17	-1.25%
Nov 06, 2024	$16.81	$14.29	-14.99%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Evolus Inc (EOLS) report earnings?

Evolus Inc (EOLS) is schdueled to report earning on Nov 11, 2025, Before Open (Confirmed).

What is Evolus Inc (EOLS) earnings time?

Evolus Inc (EOLS) earnings time is at Nov 11, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is EOLS EPS forecast?

EOLS EPS forecast for the fiscal quarter 2025 (Q3) is -0.15.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing